Medicinal Chemistry European Journal of Medicinal Chemistry
Tuning 8-hydroxyquinolines to hit GLI1 in medulloblastoma
- Starting from a known 8-hydroxyquinoline GLI1 inhibitor, analogues were grown into three sub-pockets of the GLI1 zinc-finger site.
- Lipophilic ligand efficiency guided the work, so potency gains did not come with excess greasiness.
- The lead racemate was resolved; the (R) enantiomer bound GLI1 more strongly and lowered GLI1 protein in cells, curbed SHH-type medulloblastoma cell growth and migration, and slowed tumors in a xenograft.
Growing a known hit into three sub-pockets while tracking LLE is the right way to run this series, and the tighter (R) enantiomer hints at a real binding mode. But 8-hydroxyquinolines are classic metal chelators, so I'd want on-target proof (a GLI1 zinc-finger mutant or knockdown rescue) and selectivity against other zinc proteins. How does it fare against GANT61 or arsenic trioxide?
Paper: European Journal of Medicinal Chemistry ↗ Optimization of 8-hydroxyquinolines as potent GLI1-targeting Hedgehog pathway inhibitors with anti-SHH medulloblastoma activity